Last update 08 May 2025

RhoA Y42C

Basic Info

Synonyms-
Introduction-

Related

2
Drugs associated with RhoA Y42C
RhoA Y42C(Revere)
Target
RhoA Y42C
Mechanism
RhoA Y42C inhibitors
Active Org.
Revere Pharmaceuticals, Inc.Revere Pharmaceuticals, Inc.
Originator Org.
Revere Pharmaceuticals, Inc.Revere Pharmaceuticals, Inc.
Active Indication
Stomach Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
BGS-1933
Target
RhoA Y42C
Mechanism
RhoA Y42C inhibitors
Active Org.
Bridgene Biosciences, Inc.Bridgene Biosciences, Inc.
Originator Org.
Bridgene Biosciences, Inc.Bridgene Biosciences, Inc.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with RhoA Y42C
Login to view more data
100 Translational Medicine associated with RhoA Y42C
Login to view more data
0 Patents (Medical) associated with RhoA Y42C
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free